Human rabies immunoglobulin (Guangdong Danxia Biopharm)
狂犬病人免疫球蛋白（广东丹霞生物）
Report date: 2023/02/08 13:48:48
Base Information
Drug NameHuman rabies immunoglobulin (Guangdong Danxia Biopharm)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaDiscontinued
Originator CompaniesGuangdong Danxia Biological Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGuangdong Danxia Biological Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A